|
The micromewi catheter (model: 41064-01 lot: a718250) was returned for analysis within a shipping box; within a sealed pouch; within a plastic primary bio-pouch and within a plastic secondary pouch.The micromewi catheter was returned separated into two segments.The micromewi catheter segments were decontaminated as per dpqa163.The micromewi catheter proximal segment total length was measured to be ~20.7cm and the useable length was measured to be ~10.5cm.The micromewi catheter distal segment total length was measured to be ~143.0cm.When compared to product drawing it appears the entire micromewi catheter was returned.There does not appear to be any missing segments.The micromewi catheter separated ends exhibited with stretching, flattening and jagged edges.No damages were found with the micromewi hub.No bends or kinks were found with the micromewi catheter body.No damages were found with the micromewi distal marker/tip.No other anomalies were observed.Based on the device analysis and reported information, the customer¿s report of ¿catheter separation/break¿ was confirmed.However, the cause for the catheter separation could not be determined.The was insufficient information to determine the cause of the event.Should additional information become available at a later date, the inve stigation will be re-opened and updated accordingly.(rosaj10 2019-06-16) medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|